{"id":"W4413783982","doi":"10.1016/s2152-2650(25)00381-7","title":"ORAL ABSTRACT: CT-230 Lisocabtagene Maraleucel (liso-cel) in Patients With Relapsed or Refractory (R/R) Marginal Zone Lymphoma (MZL) in the Phase 2 TRANSCEND FL Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Refractory (planetary science); Lymphoma; Internal medicine; Gastroenterology; Oncology; Cancer research; Metallurgy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005424887,0.0006281087,0.0009803053,0.0003136147,0.000280138,0.0009091222,0.0007060593,0.001209176,0.03070999],"category_scores_gemma":[0.0004610296,0.0002446103,0.000779169,0.0002412418,0.0003943336,0.0004126724,0.0003658282,0.001805368,0.003702994],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005738745,"about_ca_system_score_gemma":0.0007140443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051023,"about_ca_topic_score_gemma":0.002025067,"domain_scores_codex":[0.9998192,0.00007452783,0.00000709616,0.00002939202,0.00002388164,0.00004593423],"domain_scores_gemma":[0.9997539,0.00004438771,0.00003043771,0.00001225675,0.00001523552,0.000143777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5879558,0.01261066,0.005499402,0.001941094,0.001700919,0.0005928316,0.0001651923,0.00152371,0.02564192,0.001064769,0.06696065,0.294343],"study_design_scores_gemma":[0.5402424,0.3027588,0.034843,0.0005211913,0.002367498,0.0009694098,0.0001887228,0.001585823,0.01164135,0.0006602975,0.1041447,0.0000767353],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8758202,0.03884813,0.001739183,0.01123104,0.002881202,0.002745711,0.01486211,0.001061912,0.05081054],"genre_scores_gemma":[0.9452801,0.009188906,0.00153667,0.003934673,0.000979103,0.0009073065,0.008025139,0.0001483297,0.02999981],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03070999,"threshold_uncertainty_score":0.1027351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03010555922170812,"score_gpt":0.3463035311878021,"score_spread":0.316197971966094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}